80 related articles for article (PubMed ID: 17107055)
1. Thio-isoglobotrihexosylceramide, an agonist for activating invariant natural killer T cells.
Xia C; Zhou D; Liu C; Lou Y; Yao Q; Zhang W; Wang PG
Org Lett; 2006 Nov; 8(24):5493-6. PubMed ID: 17107055
[TBL] [Abstract][Full Text] [Related]
2. Modification of the ceramide moiety of isoglobotrihexosylceramide on its agonist activity in stimulation of invariant natural killer T cells.
Xia C; Schümann J; Emmanuel R; Zhang Y; Chen W; Zhang W; De Libero G; Wang PG
J Med Chem; 2007 Jul; 50(15):3489-96. PubMed ID: 17608465
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationship study of isoglobotrihexosylceramide analogues.
Chen W; Xia C; Wang J; Thapa P; Li Y; Talukdar A; Nadas J; Zhang W; Zhou D; Wang PG
J Org Chem; 2007 Dec; 72(26):9914-23. PubMed ID: 18020363
[TBL] [Abstract][Full Text] [Related]
4. Chemical modification of iGb3 increases IFN-gamma production by hepatic NKT cells.
Shang P; Zhang C; Xia C; Chen W; Han Q; Wang PG; Zhang J; Tian Z
Int Immunopharmacol; 2008 May; 8(5):645-53. PubMed ID: 18387506
[TBL] [Abstract][Full Text] [Related]
5. Alpha anomers of iGb3 and Gb3 stimulate cytokine production by natural killer T cells.
Yin N; Long X; Goff RD; Zhou D; Cantu C; Mattner J; Mezard PS; Teyton L; Bendelac A; Savage PB
ACS Chem Biol; 2009 Mar; 4(3):199-208. PubMed ID: 19175331
[TBL] [Abstract][Full Text] [Related]
6. Uncoupling between CD1d upregulation induced by retinoic acid and conduritol-B-epoxide and iNKT cell responsiveness.
Balreira A; Cavallari M; Sá Miranda MC; Arosa FA
Immunobiology; 2010 Jun; 215(6):505-13. PubMed ID: 19651460
[TBL] [Abstract][Full Text] [Related]
7. Chemoenzymatic syntheses of iGb3 and Gb3.
Yao Q; Song J; Xia C; Zhang W; Wang PG
Org Lett; 2006 Mar; 8(5):911-4. PubMed ID: 16494472
[TBL] [Abstract][Full Text] [Related]
8. Enhanced antitumor effects by chemical modified IGb3 analogues.
Zhou Z; Zhang C; Xia C; Chen W; Zhu H; Shang P; Ma F; Wang PG; Zhang J; Xu W; Tian Z
Mol Cancer Ther; 2011 Aug; 10(8):1375-84. PubMed ID: 21653685
[TBL] [Abstract][Full Text] [Related]
9. A divergent approach to the synthesis of iGb3 sugar and lipid analogues via a lactosyl 2-azido-sphingosine intermediate.
Cheng JM; Dangerfield EM; Timmer MS; Stocker BL
Org Biomol Chem; 2014 May; 12(17):2729-36. PubMed ID: 24652424
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of alpha-galactosylceramide (KRN7000) and isoglobotrihexosylceramide (iGb3).
Xia C; Yao Q; Schümann J; Rossy E; Chen W; Zhu L; Zhang W; De Libero G; Wang PG
Bioorg Med Chem Lett; 2006 Apr; 16(8):2195-9. PubMed ID: 16458002
[TBL] [Abstract][Full Text] [Related]
11. Globosides but not isoglobosides can impact the development of invariant NKT cells and their interaction with dendritic cells.
Porubsky S; Speak AO; Salio M; Jennemann R; Bonrouhi M; Zafarulla R; Singh Y; Dyson J; Luckow B; Lehuen A; Malle E; Müthing J; Platt FM; Cerundolo V; Gröne HJ
J Immunol; 2012 Sep; 189(6):3007-17. PubMed ID: 22875802
[TBL] [Abstract][Full Text] [Related]
12. CD1d protein structure determines species-selective antigenicity of isoglobotrihexosylceramide (iGb3) to invariant NKT cells.
Sanderson JP; Brennan PJ; Mansour S; Matulis G; Patel O; Lissin N; Godfrey DI; Kawahara K; Zähringer U; Rossjohn J; Brenner MB; Gadola SD
Eur J Immunol; 2013 Mar; 43(3):815-25. PubMed ID: 23280365
[TBL] [Abstract][Full Text] [Related]
13. Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis.
Mallevaey T; Fontaine J; Breuilh L; Paget C; Castro-Keller A; Vendeville C; Capron M; Leite-de-Moraes M; Trottein F; Faveeuw C
Infect Immun; 2007 May; 75(5):2171-80. PubMed ID: 17353286
[TBL] [Abstract][Full Text] [Related]
14. Sensitive quantitation of isoglobotriaosylceramide in the presence of isobaric components using electrospray ionization-ion trap mass spectrometry.
Li Y; Zhou D; Xia C; Wang PG; Levery SB
Glycobiology; 2008 Feb; 18(2):166-76. PubMed ID: 18048405
[TBL] [Abstract][Full Text] [Related]
15. Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency.
Porubsky S; Speak AO; Luckow B; Cerundolo V; Platt FM; Gröne HJ
Proc Natl Acad Sci U S A; 2007 Apr; 104(14):5977-82. PubMed ID: 17372206
[TBL] [Abstract][Full Text] [Related]
16. Role of marginal zone B lymphocytes in invariant NKT cell activation.
Bialecki E; Paget C; Fontaine J; Capron M; Trottein F; Faveeuw C
J Immunol; 2009 May; 182(10):6105-13. PubMed ID: 19414762
[TBL] [Abstract][Full Text] [Related]
17. Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals.
Speak AO; Salio M; Neville DC; Fontaine J; Priestman DA; Platt N; Heare T; Butters TD; Dwek RA; Trottein F; Exley MA; Cerundolo V; Platt FM
Proc Natl Acad Sci U S A; 2007 Apr; 104(14):5971-6. PubMed ID: 17372214
[TBL] [Abstract][Full Text] [Related]
18. Generation and sustained expansion of mouse spleen invariant NKT cell lines with preserved cytokine releasing capacity.
Molling JW; Moreno M; van der Vliet HJ; von Blomberg BM; van den Eertwegh AJ; Scheper RJ; Bontkes HJ
J Immunol Methods; 2007 Apr; 322(1-2):70-81. PubMed ID: 17343874
[TBL] [Abstract][Full Text] [Related]
19. Enzymatic synthesis of Gb3 and iGb3 ceramides.
Adlercreutz D; Weadge JT; Petersen BO; Duus JØ; Dovichi NJ; Palcic MM
Carbohydr Res; 2010 Jul; 345(10):1384-8. PubMed ID: 20206917
[TBL] [Abstract][Full Text] [Related]
20. Invariant natural killer T cells and immunotherapy of cancer.
Molling JW; Moreno M; van der Vliet HJ; van den Eertwegh AJ; Scheper RJ; von Blomberg BM; Bontkes HJ
Clin Immunol; 2008 Nov; 129(2):182-94. PubMed ID: 18783990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
